EC Grants Marketing Authorization for Gilead’s Epclusa for the Treatment of All Genotypes of Chronic Hepatitis C
Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg), the first pan-genotypic, single tablet...
Alere Inc q HIV-1/2 Detect Point-of-Care Molecular HIV Assay Receives WHO Prequalification
Alere Inc a global leader in rapid diagnostics, announced that its Alere™ q HIV-1/2 Detect assay has been awarded World Health Organization (WHO) prequalification,...
Norgine BV has received approval from the Dutch Ministry of Health of Xifaxan 550
Norgine B.V. announced that the Ministry of Health in the Netherlands , Ministry van Volksgezondheid, Welzijn en Sport , has approved the reimbursement of...
Takeda Pharmaceutical Co and M2Gen team up with ORIEN to speed drug development
Takeda Pharmaceutical Company Limited and M2Gen®, a healthcare informatics solutions company, have established a new collaboration to generate broad genomic data from consenting cancer...
US FDA approves expanded label for self-infusion of Glassia to treat emphysema due to severe AAT deficiency
Shire plc and Kamada Ltd a plasma-derived protein therapeutics company focused on orphan indications, announced that the US FDA has approved an expanded label...
Merck’s MK-1293 Shows Statistical Equivalence to Lantus
Merck announced results from two Phase 3 studies evaluating MK-1293, Merck’s investigational, follow-on biologic* insulin glargine candidate for the treatment of people with type...
Sanofi Announces Positive Phase 3 Results For Investigational Titratable Fixed-Ratio
Sanofi announced the presentation of the results of the pivotal Phase 3 LixiLan-O and LixiLan-L clinical trials with the investigational titratable fixed-ratio combination...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...